<?xml version="1.0" encoding="UTF-8"?>
<p>Regarding the low overall risk, our results are in line with published metadata about phase I trials with healthy subjects [
 <xref rid="b6" ref-type="bibr">6</xref>, 
 <xref rid="b10" ref-type="bibr">10</xref>], whereas the differences of included compounds and studies have to be considered. 
</p>
